Ad-hoc guidelines for managing the COVID-19 pandemic are published worldwide. We investigated international applications of such policies in the urologic-oncology community. A 20-item survey was e-mailed via SurveyMonkey to 100 international senior urologic-oncology surgeons.
The increased awareness regarding the sex gap in bladder cancer (BCa) care over the last decade may have resulted in more timely-wise referral patterns and treatment of female patients with BCa. Thus, we tested the association of sex with disease stage at presentation, as well as with cancer-specific mortality (CSM) after radical cystectomy (RC) in […]
Anti-programmed cell death ligand 1 (PD-L1)/programmed cell death 1 antibodies have shown clinical activity in platinum-treated metastatic urothelial carcinoma, resulting in regulatory approval of several agents, including avelumab (anti-PD-L1).
(UroToday.com) The 2020 SIU virtual annual meeting featured a joint session of the SIU-SUO-ESOU groups, with Dr. Morgan Roupret from Paris discussing new perspectives in the management of invasive upper tract urothelial carcinoma (UTUC).
(UroToday.com) During the Controversies in the Management of Kidney Cancer session at this year’s virtual SIU annual congress, Dr. Amlesh Seth discussed potentially controversial aspects of the management of patients with small renal masses.
(UroToday.com) The 2020 Société Internationale d’Urologie (SIU) virtual annual meeting featured a joint session of the SIU-SUO-ESOU groups, with Dr. Christopher Evans discussing germline and somatic mutations in advanced prostate cancer.
(UroToday.com) In the Controversies in the Management of Kidney Cancer session of this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Axel Bex and Dr. Jose Karam debated the role of cytoreductive nephrectomy with kidney cancer, taking the con and pro sides of this argument, respectively. Dr. Karam began highlighting the cases of three […]
(UroToday.com) In the Controversies in the Management of Kidney Cancer session of this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Axel Bex and Dr. Jose Karam debated the role of cytoreductive nephrectomy with kidney cancer, taking the con and pro sides of this argument, respectively. Dr. Bex began by emphasizing that such a […]
(UroToday.com) As part of the Master Class session on genomic testing and recurrence in prostate cancer at the 2020 Société Internationale d’Urologie (SIU) virtual annual meeting, Dr. Shusuke Akamatsu discussed liquid biopsy in prostate cancer. Dr. Akamatsu started by outlining the landscape of advanced prostate cancer, starting with Dr. Huggins innovating surgical castration in 1941 through olaparib being approved […]
(UroToday.com) In the Indian Urology Symposium held in conjunction with this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Sudhir Rawal discussed the role of systemic therapy in patients with metastatic renal cell carcinoma (mRCC).
